idarubicin ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antineoplastics, daunorubicin derivatives 1414 58957-92-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • idarubicin
  • 4-Demethoxydaunomycin
  • 4-Demethoxydaunorubicin
  • demethoxydaunorubicin
  • idarubicin hydrochloride
  • idarubicin HCl
An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.
  • Molecular weight: 497.50
  • Formula: C26H27NO9
  • CLOGP: 0.84
  • LIPINSKI: 0
  • HAC: 10
  • HDO: 5
  • TPSA: 176.61
  • ALOGS: -2.81
  • ROTB: 3

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

FDA Adverse Event Reporting System (Male)

FDA Adverse Event Reporting System (Geriatric)

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

idarubicin